|
| 1 |
|
Conditions listed in this trial |
|
|
Childhood Germ Cell Tumor |
|
|
Extragonadal Germ Cell Tumor |
|
|
Kidney Cancer |
|
|
Liver Cancer |
|
|
Neuroblastoma |
|
|
Ovarian Cancer |
|
|
Sarcoma |
|
| 2 |
|
Additional conditions recognized in this trial |
|
|
Carcinoma, Renal Cell |
|
|
Central Nervous System Neoplasms |
|
|
Kidney Neoplasms |
|
|
Liver Neoplasms |
|
|
Neoplasms, Germ Cell and Embryonal |
|
|
Nervous System Neoplasms |
|
|
Ovarian Neoplasms |
|
| 3 |
|
More general conditions related to this trial |
|
|
Adenocarcinoma |
|
|
Adnexal Diseases |
|
|
Carcinoma |
|
|
Digestive System Diseases |
|
|
Digestive System Neoplasms |
|
|
Endocrine Gland Neoplasms |
|
|
Endocrine System Diseases |
|
|
Genital Diseases, Female |
|
|
Genital Neoplasms, Female |
|
|
Gonadal Disorders |
|
|
Kidney Diseases |
|
|
Liver Diseases |
|
|
Neoplasms |
|
|
Neoplasms by Histologic Type |
|
|
Neoplasms by Site |
|
|
Neoplasms, Connective and Soft Tissue |
|
|
Neoplasms, Glandular and Epithelial |
|
|
Neoplasms, Nerve Tissue |
|
|
Neoplasms, Neuroepithelial |
|
|
Nervous System Diseases |
|
|
Neuroectodermal Tumors |
|
|
Neuroectodermal Tumors, Primitive |
|
|
Neuroectodermal Tumors, Primitive, Peripheral |
|
|
Ovarian Diseases |
|
|
Urogenital Neoplasms |
|
|
Urologic Diseases |
|
|
Urologic Neoplasms |
|
| 4 |
|
Interventions listed in this trial |
|
|
O6-benzylguanine |
|
|
temozolomide |
|
| 5 |
|
Additional drug interventions recognized in this trial |
|
|
O(6)-benzylguanine |
|
| 6 |
|
More general drug interventions related to this trial |
|
|
Alkylating Agents |
|
|
Antineoplastic Agents |
|
|
Antineoplastic Agents, Alkylating |
|
|
Enzyme Inhibitors |
|
|
Molecular Mechanisms of Pharmacological Action |
|
|
Pharmacologic Actions |
|
|
Therapeutic Uses |
|
| 7 |
|
Sponsors listed in this trial |
|
|
NCI - Center for Cancer Research-Medical Oncology |
|
|
National Cancer Institute (NCI) |
